A Phase 1, Randomized Investigator-And-Subject-Blind, Sponsor Open, Placebo Controlled Two-Part Study To Characterize The Pharmacokinetics And Pharmacodynamics Of Single Doses Of Pf-05297909 In Healthy Adult Subjects
This study is designed to observe the safety and concentrations of PF-05297909 and proteins in both blood and cerebrospinal fluid after a single dose of PF-05297909 in healthy adults.
100 项与 PF-5297909 相关的临床结果
100 项与 PF-5297909 相关的转化医学
100 项与 PF-5297909 相关的专利(医药)
100 项与 PF-5297909 相关的药物交易